Patents Assigned to Universite Pierre et Marie Curie (Paris 6)
  • Patent number: 9404914
    Abstract: The invention relates to a microfluidic system for controlling a concentration profile of molecules capable of stimulating a target, for example formed by an assembly of living cells, this system comprising: —a microfluidic device (1) comprising at least one microfluidic channel (4) equipped with at least one inlet orifice (21) and with at least one outlet orifice (22) for at least one fluid; —at least one means for supplying the microfluidic channel (4) with at least one fluid comprising molecules capable of stimulating the target; —at least one chamber (8) or another microfluidic channel comprising a base (6) intended to receive the target; and —at least one microporous membrane (5) separating the chamber (8) or the other microfluidic channel from the microfluidic channel (4), said microporous membrane (5) being positioned away from the base (6) so that when the supply means provides the microfludic channel (4) with said at least one fluid flowing in laminar flow in contact with the microporous membrane (5)
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: August 2, 2016
    Assignees: Centre National de la Recherche Scientifique-CNRS, Ecole Normale Supérieure, Université Pierre et Marie Curie (Paris 6), Fonds De L'ESPCI-Georges Charpak, Univerité Bordeaux Segalen
    Inventors: Maxime Dahan, Mathieu Morel, Jean-Christophe Galas, Vincent Studer, Denis Bartolo
  • Patent number: 9389233
    Abstract: The present invention concerns an in vitro method for diagnosing a myeloid tumor or a lymphoid tumor in a subject, which comprises the step of analyzing a biological sample from said subject by (i) detecting the presence of a mutation in the Ten Eleven Translocation protein family member 2 gene (TET2) coding for the polypeptide having the sequence SEQ ID NO:2, and/or (ii) analyzing the expression of the TET2 gene; wherein the detection of such a TET2 mutation, of the absence of expression of TET2 or of the expression of a truncated TET2 is indicative of a subject developing or predisposed to develop a myeloid tumor or a lymphoid tumor.
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: July 12, 2016
    Assignees: Institute National de la Sante et de la Recherche Medicale (Inserm), Institut Gustave-Roussy, Assistance Publique-Hopitaux de Paris, Centre Henri Becquerel, Universite Paris Descartes, Universite Pierre et Marie Curie (PARIS 6), Universite Paris-Sud
    Inventors: Franck Viguie, Olivier Bernard, Michaela Fontenay, Christian Bastard, Francois Delhommeau, William Vainchenker
  • Patent number: 9364514
    Abstract: A chimeric peptide construct having a cell penetrating peptide linked to a pro-apoptotic peptide. The construct can be used for treating a tumor in combination with an anti-tumor agent. Also disclosed is a method for treating a tumor with the chimeric peptide construct and a chemotherapeutic agent.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: June 14, 2016
    Assignees: Institute Curie, Universite Pierre et Marie Curie (Paris 6)
    Inventors: Angelita Rebollo Garcia, Fariba Nemati, Didier Decaudin
  • Publication number: 20160161450
    Abstract: Device for the representation, in a frequency-wave number reference frame f-k, of the propagation of an ultrasound wave in a dihedral guide (1), which comprises ultrasound emitters (2) referenced by “Ej” with j an integer varying between 1 and N, N a strictly positive integer and ultrasound receivers (3) referenced by “Ri” with i an integer varying between 1 and M, M a strictly positive integer, the receivers being disposed spatially over a first segment of a straight line according to a regular pitch “A”, which comprises means for processing the signal received by the receivers, originating from the emitters, and in which the processing means comprise means for calculating a modified discrete spatial Fourier transform, for a spatial integration variable “x”, centered in the middle of said first segment and running through the receivers in the direction of increasing x, and for a wave vector k(x) equal to a product k.
    Type: Application
    Filed: July 4, 2014
    Publication date: June 9, 2016
    Applicants: Azalée, Centre National de la Recherche Scientifique, Université Pierre et Marie Curie - Paris 6
    Inventors: Ludovic Moreau, Jean-Gabriel Minonzio, Maryline Talmant, Pascal Laugier
  • Patent number: 9359589
    Abstract: The invention relates to the use of at least one chelating agent, including an iron chelating agent, in order to stimulate the growth of magnetotactic bacteria.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: June 7, 2016
    Assignees: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Edouard Alphandery, Iméne Chebbi
  • Patent number: 9353155
    Abstract: A cell-penetrating peptide is described. Also described is a pro-apoptotic agent including the cell-penetrating peptide and a pro-apoptotic peptide linked thereto. The pro-apoptotic agent is useful for inhibition of in vitro cell proliferation and for treatment of tumors.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: May 31, 2016
    Assignees: Universite Pierre et Marie Curie (Paris 6), Institute Curie
    Inventors: Angelita Rebollo Garcia, Fariba Nemati, Didier Decaudin, Jeronimo Bravo Sicilia, Jesus Maria Fominaya Gutierrez
  • Patent number: 9339279
    Abstract: An implant and guide are described, together with methods for configuring the same. The implant and guide are for maxillofacial osteosynthesis and may be provided as a kit. Three-dimensional models of the pre- and post-operative anatomy are used to define attachment points. These attachment points are used to define a structure for the implant and the guide.
    Type: Grant
    Filed: June 11, 2015
    Date of Patent: May 17, 2016
    Assignees: OBL S.A., Université Pierre et Marie Curie (Paris 6), Assistance Publique—Hôpitaux de Paris (Paris)
    Inventors: Guillaume Dubois, Patrick Goudot, Thomas Schouman
  • Patent number: 9327242
    Abstract: This method comprises bringing drops to be separated into contact with an interface (40) suitable for allowing an osmotic equilibrium between the content of each drop to be separated. The method comprises an osmotic flow between the drops (20A) of the first group of drops through the interface (40) in order to modify the density of each drop (20A) of the first group of drops and the separation of the drops (20A, 20B) according to the density thereof or a combination of the density and the volume in order to isolate the drops (20A) of the first group of drops from the drops (20B) of a second group of drops.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: May 3, 2016
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.), UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ECOLE NORMALE SUPERIEURE DE LYON, UNIVERSITE PARIS DIDEROT—PARIS 7
    Inventors: Gaël Yvert, Jérôme Bibette, Jean-Marie Baudry, Laurent Boitard, Nicolas Bremond, Denis Cottinet
  • Patent number: 9308079
    Abstract: The endovascular prosthesis includes a first expandable framework and a first jacket for the first framework, the first framework and the first jacket forming a first channel when the first framework is in the expanded state. The first framework and the first jacket each have at least one opening, which openings are arranged substantially opposite one another and through which a sleeve is received, the sleeve having a first end and a second end, the perimeter of the first end being attached to the perimeter of the opening of the first jacket, while the second end extends inside the first channel.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: April 12, 2016
    Assignees: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Fabien Koskas, Julien Molina, Chika Cho
  • Patent number: 9304125
    Abstract: The present invention relates to methods and devices for observing the cell division, in particular the cytokinetic ring, methods for preparing such devices, methods for studying modifications of cell division, and methods for screening compounds of interest which enhance or inhibit cell division.
    Type: Grant
    Filed: February 11, 2010
    Date of Patent: April 5, 2016
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ROCKEFELLER UNIVERSITY, UNIVERSITE PIERRE ET MARIE CURIE PARIS 6, INSTITUT CURIE
    Inventors: Daniel Riveline, Axel Buguin
  • Patent number: 9306594
    Abstract: A continuous-time sigma delta radio frequency modulator is provided, including at least two LC resonators coupled in parallel by a coupling capacitive element, producing an at least 4th-order bandpass filter, a frequency response of the bandpass filter presenting at least two poles that can be brought closer together or moved further apart depending on the capacitive element value; a feedback loop for shaping the quantization noise with a predetermined noise transfer function; and an adder for receiving: at one of its inputs an analog signal; and at its other input a signal provided by the feedback loop; and the output of which is linked to the input of the bandpass filter, the feedback loop including a finite impulse response filter, the coefficients of which being calculated to obtain a noise transfer function which maximizes the signal-to-noise ratio in a signal bandwidth while ensuring the stability of the feedback loop.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: April 5, 2016
    Assignees: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Hassan Aboushady, Nicolas Beilleau, Diomadson Belfort, Ahmed Ashry
  • Patent number: 9275618
    Abstract: The invention relates to a haptic controller comprising a base (2), at least one maneuvering body (8) which is movably mounted on the base such that it can be moved under the action of a user, mechanical connection means (4, 15) comprising at least one deformable abutment consisting of an elastomer material between the maneuvering body and the base, and suitable for exerting a monotonous, non-linear resistive effort against an actuating effort of the maneuvering body, at least one sensor (12) placed in the haptic controller in such a way as to generate a signal representative of said actuating effort, and associated built-in or remote means (18) for processing the signal generated by the sensor, in order to supply an output signal for controlling at least one characteristic of a sound.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: March 1, 2016
    Assignees: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Laurent Quartier, Eric Simon
  • Patent number: 9263683
    Abstract: A method for employing certain cobalt complexes as electron donors and in combination with an electron acceptor is provided for preparing an active layer in a photovoltaic conversion cell, as well as to the photovoltaic conversion cell in which the electron donor of the active layer includes such cobalt complexes.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: February 16, 2016
    Assignees: Centre National De La Recherche Scientifique, Universite Pierre Et Marie Curie (Paris 6)
    Inventors: Corinne Aubert, Ludovic Tortech, Vincent Gandon, Denis Fichou, Max Malacria, Guillaume Bertrand
  • Publication number: 20160040028
    Abstract: A straight, branched or cross-linked polymer, including, per 100 mol %: a) a mole fraction from 75% to 99.95% of monomer units from an N,N-dialkyl acrylamide; b) a mole fraction from 0.05% to 1% of monomer units from a monomer of formula (I): CH2=C(Ri)-C(=0)-0-[(CH2-CH(R2)-0]n-R3 (I); c) optionally a mole fraction higher than 0% to 24% either of monomer units from a monomer including a free strong acid function, partially or totally salified, or of monomer units from a monomer of formula (II): CH2=C(R4)-C(=0)-Y-(CH2)m-N(R5)(R6) (II); d) optionally a mole fraction higher than 0% to 1% of a diethylene or polyethylene cross-linking monomer. Also, a method for treating a surface made of a hydrophobic material, using the polymer, and an aqueous, hydro-organic or organic solution including the polymer for modifying interactions between the species contained the solution and the hydrophobic surface.
    Type: Application
    Filed: March 21, 2014
    Publication date: February 11, 2016
    Applicants: SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT CURIE, UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Jean-Louis VIOVY, Olivier BRAUN
  • Patent number: 9250454
    Abstract: A method and a system is provided for configuring a device for correcting the effect of a medium on a light signal having propagated through the medium, the device including at least one optical element whose phase profiles are individually adjustable. The configuring system and method include propagating a reference signal and a disordered signal obtained at the output of the medium through the correcting device. An interference parameter is measured and optimized by modifying the phase profile of each of the optical elements of the correcting device. A method and a system is also provided for correcting the effect of a medium on a light signal having propagated through the medium.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: February 2, 2016
    Assignees: Universite Pierre et Marie Curie (Paris 6), Centre National de la Recherche Scientifique, Ecole Normale Superieure, Australian National University
    Inventors: Jean-François Morizur, Hans Bachor, Nicolas Treps
  • Publication number: 20160018416
    Abstract: A new dual biomarker of neurodegeneration and of neuroregeneration
    Type: Application
    Filed: February 22, 2013
    Publication date: January 21, 2016
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ECOLE NORMALE SUPERIEURE, COLLEGE DE FRANCE
    Inventors: Philippe MARIN, Eric THOUVENOT, Genevieve NGUYEN, Matthias GROSZER
  • Patent number: 9213902
    Abstract: A computer receives asynchronous information originating from a light sensor (10) having a pixel matrix disposed opposite a scene. The asynchronous information comprises, for each pixel of the matrix, successive events originating from this pixel and depending on variations in light in the scene. For a place of estimation (p) in the matrix of pixels and an estimation time (t), the computer selects a set (Sp t) of events originating from pixels included in a spatial neighborhood (??) of the place of estimation and which have occurred in a time interval (?) defined with respect to the estimation time, such that this set has at most one event per pixel of the spatial neighborhood. The computer quantifies the variations in the times of occurrence of the events of the set selected as a function of the positions, in the matrix, of the pixels from which these events originate.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: December 15, 2015
    Assignees: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS
    Inventors: Ryad Benosman, Siohoi Ieng
  • Publication number: 20150343202
    Abstract: A biocompatible carbon based electrode, and its preparation process are described. The electrode is formed by first and second biocompatible chemically oxygen terminated or H-terminated carbon-based materials. The first material is configured to promote the growth or at least the direct interfacing of adult neurons on the first material without substantially promoting the growth and direct interfacing of glial cells on the first material. The second material presents a peptide coating to promote the growth and at least the direct interfacing of adult glial cells.
    Type: Application
    Filed: December 24, 2013
    Publication date: December 3, 2015
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Serge PICAUD, Amel BENDALI, Philippe BERGONZO, Valerie FOSTER-FRADOT, Jose-Alain SAHEL
  • Publication number: 20150329857
    Abstract: The present invention relates to the use of interferent RNAs that silence PW1 expression in order to activate adult stem cells in vitro or in vivo, in particular in the context of regenerative medicine.
    Type: Application
    Filed: December 28, 2012
    Publication date: November 19, 2015
    Applicant: Universite Pierre et Marie Curie (PARIS 6)
    Inventors: David Sassoon, Giovanna Marazzi, Vanessa Besson
  • Patent number: 9181294
    Abstract: The present invention describes the use of nucleoside analogs for the treatment of viral infections, in particular of an HIV infection, and also compositions comprising at least one of these analogs, and a method for evaluating the sensitivity to said treatment.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: November 10, 2015
    Assignee: Universite Pierre Et Marie Curie (Paris 6)
    Inventors: Vincent Calvez, Anne-Genevieve Marcelin, Cathia Soulie, Melanie Etheve-Quelquejeu, Matthieu Sollogoub